Lyell Immunopharma Market Cap

Lyell Immunopharma has a market cap or net worth of $692.16 million as of May 17, 2024. Its market cap has increased by 10.04% in one year.

Market Cap

692.16M

Enterprise Value

220.73M

1-Year Change

10.04%

Ranking

#2727

Market Cap Chart

Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $692.16M, a decrease of -83.23%. That is a compound annual growth rate of -45.77%.

Market Cap History

Date	Market Cap	% Change
May 17, 2024	698.50M	-1.44%
May 16, 2024	708.70M	6.51%
May 15, 2024	665.40M	2.76%
May 14, 2024	647.50M	5.82%
May 13, 2024	611.90M	-2.44%
May 10, 2024	627.20M	-8.20%
May 9, 2024	683.20M	7.20%
May 8, 2024	637.30M	-1.58%
May 7, 2024	647.50M	-
May 6, 2024	647.50M	7.97%
May 3, 2024	599.70M	-1.66%
May 2, 2024	609.80M	3.01%
May 1, 2024	592.00M	7.36%
Apr 30, 2024	551.40M	-3.55%
Apr 29, 2024	571.70M	3.68%
Apr 26, 2024	551.40M	-1.36%
Apr 25, 2024	559.00M	-4.35%
Apr 24, 2024	584.40M	-5.74%
Apr 23, 2024	620.00M	1.24%
Apr 22, 2024	612.40M	8.08%
Apr 19, 2024	566.60M	-4.29%
Apr 18, 2024	592.00M	-2.10%
Apr 17, 2024	604.70M	-1.26%
Apr 16, 2024	612.40M	0.43%
Apr 15, 2024	609.80M	-20.27%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Stoke Therapeutics	736.98M
Phibro Animal Health	729.27M
Wave Life Sciences	724.96M
Sage Therapeutics	722.18M
Cogent Biosciences	711.84M
PACS Group	702.32M
AnaptysBio	699.08M
Autolus Therapeutics	681.68M

Market Cap Rankings